Cell therapy biotech raises $120M to advance therapy to treat common cornea condition by Charlotte Schubert on April 12, 2022April 12, 2022 at 3:48 pm Aurion Biotech has raised $120 million to advance its cell therapy for an eye disorder that affects millions of people. The startup is a spinoff of Seattle eye care company… Read More